Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...
A new study by the National Cancer Research Center (CNIO) has identified several sets of genes related to the predisposition ...
The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...
Proteinuria (protein in urine) is common with complement 3 glomeropathy and is a strong predictor of disease progression and end-stage kidney failure.
This knowledge would help identify individuals who could benefit from early detection programmes, which are essential for a ...
From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...
ReAlta Life Sciences Inc. ("ReAlta" or the "Company"), a clinical-stage biopharmaceutical company focused on safely targeting neutrophils and central components of the complement system to ...
This review synthesizes clinical, genetic, and mechanistic evidence showing that suPAR and related uPAR fragments are ...
Autolus will evaluate Cellares’ fully automated, high-throughput manufacturing platform in preparation for expansion into new indicationsSOUTH SAN FRANCISCO, Calif. and LONDON, Jan. 06, 2026 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback